_256_384.png){kind=logo}
Digitisation | February 09, 2024
Qure.ai adds new FDA breakthrough device status for qSpot-TB
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Marks remarkable acceleration in innovation using AI technology
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Announces pilot project for rapid, remote diagnosis of tuberculosis
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)